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rotator interval (RI), anterior joint capsule (AJC), axillary 
recess (AR), and posterior joint capsule (PJC) from the 
attenuation-corrected axial images.
Results Mean SUVmax values for four ROIs of the 
affected shoulder were significantly higher than those of 
the unaffected shoulder. Mean SUVmax values of RI and 
AR were significantly higher than those of AJC and PJC 
and mean SUVmax of AJC was significantly higher than 
that of PJC in the affected side. Three recognizable patterns 
of increased uptake were noted: (1) AR dominant type (15 
patients); (2) RI dominant type (9 patients); (3) both RI 
and AR dominant type (11 patients). The SUVmax of AR 
showed negative correlation with abduction and forward 
flexion. The SUVmax of RI showed negative correlation 
with external rotation and internal rotation. The SUVmax 
of AJC showed negative correlation with all ROMs. How-
ever, there was no significant correlation between the SUV-
max of PJC and any ROM.
Conclusion Our study demonstrates that the anterior–
inferior capsular portion, including RI and AR, is the main 
pathologic site of idiopathic FS and reveals significant cor-
relations between ROM and metabolic parameters on 18F-
FDG PET/CT. These results imply that AR and RI lesions 
are related to elevational limitations and rotational limita-
tions, respectively.
Keywords Frozen shoulder · Pathophysiology · 18F-FDG 
PET/CT · Axillary recess · Rotator interval
Introduction
Frozen shoulder (FS) is one of the most common shoulder 
disorders which is characterized by shoulder pain and lim-
ited range of motion (ROM) [1]. FS is thought to be the 
Abstract 
Objective Because positron emission tomography/com-
puted tomography (PET/CT) using fluorine-18-fluorode-
oxyglucose (18F-FDG) can be used to visualize inflamma-
tion of the musculoskeletal system, it may help elucidate 
the pathophysiology of frozen shoulder (FS). The purpose 
of this study was to characterize the uptake pattern on 18F-
FDG PET/CT in patients with idiopathic FS and to deter-
mine if there is a correlation between its metabolic param-
eters and clinical findings.
Methods 18F-FDG PET/CT was conducted to 35 patients 
with unilateral idiopathic FS. Clinical data including pain, 
functional scores, and passive range of motion (ROM) were 
collected. Maximum standardized uptake values (SUV-
max) were measured at the four regions of interest (ROIs): 
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result of inflammation in the joint synovium triggered by 
unknown factors and then a gradual onset of fibrosis [2, 
3]. However, the exact pathophysiology of idiopathic FS 
remains debatable.
Arthroscopy and imaging studies have demonstrated loss 
of axillary recess (AR) fold, capsular contracture, rotator 
interval (RI) thickening and fibrosis including contracture 
of the coracohumeral ligament, and adhesion of the sub-
acromial bursa in FS [3–7]. Clarifying the pathologic site 
may affect treatment methods (e.g., optimizing injection 
sites or the extent of capsular release). Although magnetic 
resonance image (MRI) is useful when diagnosing shoulder 
pain, it has high rate of false positives [4, 8]. Recent stud-
ies demonstrated that specific patterns in positron emission 
tomography (PET) using fluorine-18-fluorodeoxyglucose 
(18F-FDG) are related to shoulder diseases including osteo-
arthritis and FS [9–12]. Because positron emission tomog-
raphy/computed tomography (PET/CT) using 18F-FDG can 
visualize inflammation of the musculoskeletal system and 
provide a comparison of both sides, we expected that PET/
CT would supply new information about the pathophysiol-
ogy of FS.
Although the diagnostic extent or patterns of ROM in FS 
have not been standardized, it is well accepted that FS has 
ROM limitation in all directions. Cyriax [13] proposed that 
tightness in a joint capsule would result in a specific pattern 
of proportional motion restriction. However, most shoulder 
specialists have felt that there is heterogeneity of ROM lim-
itation in FS. Some studies also reported that no single cap-
sular pattern emerges in FS [14, 15]. To date, there are few 
reports that explain the relationship between the pathologic 
sites and patterns of ROM limitation.
The purpose of this study was to determine whether 
there are specific patterns or outstanding sites of 18F-FDG 
uptake of the shoulder joint on 18F-FDG PET/CT for idio-
pathic FS and to elucidate which areas of uptake are related 
to the patterns of ROM limitation. We hypothesized that 
18F-FDG uptake would be focused in the AR and RI, and 
uptake in AR would be related to elevational limitations 
and uptake in RI would be related to rotational limitations.
Materials and methods
Study subjects
This prospective study was conducted from February to 
July 2015 in patients who were diagnosed as having uni-
lateral idiopathic FS. The ethics committee of our institu-
tion approved this study. The purpose of the study and the 
possibility of radio-hazard were explained to all patients. 
The patients were willing to participate in this study 
and provided written informed consent. We performed 
18F-FDG PET/CT without charge for a total of 35 patients 
enrolled. Standard and meticulous history taking and 
physical examination to differentiate idiopathic FS from 
other shoulder disorders were evaluated. Inclusion cri-
teria included: shoulder pain with limitation of passive 
ROM of greater than 30° in two or more planes of move-
ment; stage II or III defined by Hannafin and Chiaia [16]. 
Plain radiography, MRI and/or diagnostic ultrasonog-
raphy were also routinely used to exclude other shoul-
der problems including symptomatic rotator cuff tears, 
calcific tendinitis, and osteoarthritis. Exclusion criteria 
included: FS secondary to endocrine disorders (diabetes 
mellitus, thyroid disease); rheumatic diseases; infection; 
trauma; fracture; previous shoulder or adjacent region 
surgeries or interventions; cervical radiculopathy; rota-
tor cuff disease; osteoarthritis; history of cancer; previous 
steroid injection within 3 months. Of the 45 patients eli-
gible for this study, 5 patients were excluded because of 
bilateral involvement, 4 refused to perform this study, 1 
was excluded because of history of breast cancer.
Clinical assessment included visual analog scale 
(VAS) pain score, American Shoulder and Elbow Sur-
geons (ASES) score, and Subjective Shoulder Value 
(SSV). Passive ROMs including forward flexion, abduc-
tion, external rotation with arm at the side, and internal 
rotation at the back were evaluated.
18F-Fluorodeoxyglucose positron emission tomography/
computed tomography
All patients fasted for at least 6  h before the PET/CT. 
Blood glucose levels were measured and were lower than 
150 mg/dL in all patients. PET/CT was performed using 
a Biograph mCT PET/CT scanner (Siemens Healthcare). 
Regional CT of shoulders was performed with a con-
tinuous spiral technique on a 64-slice helical CT scanner 
(CARE dose 4D and CARE KV on quality reference mAs 
55 and reference KV 120, respectively; pitch 1.0; section 
width 3 mm) in the supine position with the arms down. 
Next, an emission scan was performed at 90 s per bed at 
60 min after the intravenous administration of 3.5 MBq/
kg of 18F-FDG. CT data were used for attenuation cor-
rection and PET images were reconstructed with a three-
dimensional (3D) ordered-subsets expectation maximiza-
tion algorithm (21 subsets, two iterations). CT and PET 
scan data were coregistered on a dedicated workstation 
(SingoMMWP VE40A, Siemens Healthcare). 18F-FDG 
PET scan images were displayed on the transaxial, cor-
onal, and sagittal planes, and with rotating 3D images 
(voxel size = 2.5 × 2.5 × 3.0  mm, transaxial resolu-
tion = 4 mm FWHM).
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Image analysis
An experienced nuclear medicine specialist evaluated qual-
itatively for location, distribution, and relative intensity of 
radiotracer uptake in the shoulder joint to identify the out-
standing pattern of FS. We evaluated the intensity of 18F-
FDG accumulation as standardized uptake value (SUV), 
defined as the tissue concentration divided by the activity 
injected per body weight. SUVs were measured at the four 
regions of interest (ROIs): RI, anterior joint capsule (AJC), 
AR, and posterior joint capsule (PJC) from the attenuation-
corrected axial images (Fig. 1). Maximum SUV (SUVmax) 
at a pixel with highest uptake of 18F-FDG within each ROI 
was recorded. SUVs at the unaffected shoulder were also 
measured for control group.
Statistical analysis
MedCalc version 14.12.0 (MedCalc Software bvba, Bel-
gium) was used for analysis. Paired t tests were used to 
compare SUVmax between affected and unaffected shoul-
ders. One-way analysis of variance (ANOVA) was used 
to compare  SUVmax of four ROIs in the affected shoulder. 
If the one-way ANOVA demonstrated statistically signifi-
cant differences among the four ROIs, multiple comparison 
result was performed by contrast as Bonferroni correction. 
For statistical analysis of internal rotation, we converted 
values into contiguously numbered groups: T1–T12 for 
1–12; L1–L5 for 13–17; sacrum to 18; pelvis to 19; and 
buttock to 20. The correlation between clinical parameters 
and SUVmax was assessed using the Pearson correlation 
coefficient. All statistical tests were conducted at the two-
sided 5% significance level and all p values reported were, 
correspondingly, two-sided.
Results
The characteristics of the study population are given in 
Table 1. The average age was 53.6 years and a greater pop-
ulation was of female gender (65.7%). The average duration 
of symptoms was 6.1 months. Thirty patients had stage II 
FS and five had stage III FS.
Quantitative analysis of 18F-FDG PET/CT
Mean SUVmax values for RI, AJC, AR, and GT of the 
affected shoulder were significantly higher than those of 
the unaffected shoulder (all p < 0.001) (Table 2). The high-
est SUVmax in the affected shoulder was noted at AR 
among regional metabolic parameters, followed by RI and 
AJC. The SUVmax of PJC in affected shoulder was signifi-
cantly higher than that of unaffected shoulder, although the 
difference was small. There were significant differences of 
mean SUVmax among four ROIs in the affected shoulder 
(p < 0.001). These results indicated that the mean SUVmax 
values of RI and AR were significantly higher than those 
Fig. 1  Standardized uptake values measured at the four regions of 
interest from the attenuation corrected axial images on 18F-FDG PET/
CT. a Rotator interval. b Anterior and posterior joint capsule. c Axil-
lary recess
Table 1  Patients’ characteristics
Variables Values
Age (years) 53.6 ± 7.5
Sex (M:F) 12:23
Duration of symptoms (months) 6.1 ± 3.9
Stage (I:II:III:IV) 0:35:5:0
ASES score 38.7 ± 13.2
SSV (%) 34.8 ± 15.1%
VAS pain score 6.5 ± 1.5
ABD (°) 86.7° ± 21.0°
FF (°) 102.6° ± 21.0°
ER (°) 31.6° ± 13.3°
IR score 17.8 ± 1.9
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of AJC and PJC (p < 0.001) and the mean SUVmax of AJC 
was significantly higher than that of PJC (p < 0.001).
Visual analysis of 18F-FDG PET/CT
The predominant pattern of 18F-FDG uptake in the affected 
shoulder was increased uptake at AR and/or RI, and spread-
ing into AJC. Three recognizable patterns of increased 
uptake were noted (Fig. 2): (1) AR dominant type (with or 
without spreading of the uptake into AJC and or RI); (2) RI 
dominant type (with or without spreading of the uptake into 
AJC and/or AR); (3) both RI and AR dominant type with 
equivalently hot uptake at both RI and AR (with or without 
spreading of the uptake into AJC). Of the 35 patients with 
FS, 15 (42.9%) were AR dominant type, 9 (25.7%) were RI 
dominant type, and 11 (31.4%) were both RI and AR domi-
nant type. There was no increased uptake in the unaffected 
shoulder.
Correlation between regional metabolic parameters 
and range of motion
The SUVmax of RI showed negative correlation with 
external rotation and internal rotation (r = −0.47 and 0.44, 
p = 0.005 and 0.008, respectively). The SUV of AR showed 
negative correlation with abduction and forward flexion 
(r = −0.46 and −0.46, p = 0.006 and 0.005, respectively). 
The SUV of AJC showed significant correlation with 
abduction, forward flexion, external rotation and inter-
nal rotation (r = −0.36, −0.34, −0.52, and 0.50, p = 0.033, 
0.048, 0.001 and 0.002, respectively). However, there was 
no significant correlation between the SUV of PJC and 
ROM (Table 3).
Table 2  Comparison of 
metabolic parameters
a Comparison between affected and unaffected side for each ROI
b Multiple comparison by contrast for four ROIs in affected side
*Statistically significant




p  valuea ROIs  comparisonb
RI 6.17 ± 2.59 2.19 ± 0.40 <0.001* RI, AR > AJC > PJC (p < 0.001*)
AJC 4.91 ± 1.17 2.15 ± 0.44 <0.001*
AR 6.85 ± 2.35 1.92 ± 0.37 <0.001*
PJC 2.15 ± 0.48 1.51 ± 0.26 <0.001*
Fig. 2  Three recognizable patterns of increased 18F-FDG uptake. a 
AR dominant type. b RI dominant type. c Both RI and AR dominant 
type
Table 3  Correlation between range of motion and regional metabolic 
parameters
*Statistically significant
ABD FF ER IR 
score
RI—SUVmax r −0.22 −0.24 −0.47 0.44
p value 0.200 0.157 0.005* 0.008*
AJC—SUVmax r −0.36 −0.34 −0.52 0.50
p value 0.033* 0.048* 0.001* 0.002*
AR—SUVmax r −0.46 −0.46 −0.23 0.17
p value 0.006* 0.005* 0.194 0.345
PJC—SUVmax r −0.10 −0.09 0.01 −0.16
p value 0.578 0.593 0.968 0.365
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Correlation between clinical scores and metabolic 
parameters
There was no significant correlation between clinical scores 
and metabolic parameters (Table 4).
Discussion
We evaluated cross-sectional 18F-FDG PET/CT findings in 
patients with idiopathic FS who had relatively homogenous 
characteristics. All patients had significant increases of 18F-
FDG uptake at the AR, RI, AJC and PJC of the affected 
shoulder compared to the unaffected shoulder. However, 
the areas with mean SUVmax >2.5 are AR, RI, and AJC. 
These results suggest that the main pathologic sites of FS 
are the AR, RI, and AJC. We also found that the areas of 
18F-FDG uptake and the patterns of ROM limitation are 
closely related. The SUVmax of AR showed negative cor-
relation with abduction and forward flexion. The SUVmax 
of RI showed negative correlation with external rotation 
and internal rotation. The SUVmax of AJC showed nega-
tive correlation with all ROMs. However, there was no sig-
nificant correlation between the SUVmax of PJC and any 
ROM.
The main pathologic sites of FS are known to be the 
coracohumeral ligament and anterosuperior and inferior 
glenohumeral joint synovium and capsule [1, 17–19]. 
This knowledge has been confirmed by arthroscopic and 
MRI findings. Previous arthroscopic findings in refrac-
tory FS demonstrated inflamed synovium of the RI region 
with thickened capsule or hyalinization in the RI capsule 
and the coracohumeral ligament [17]. Using dynamic MRI 
with intravenous gadolinum administration, Tamai et  al. 
[19] illustrated an increased perfusion of gadolinum from 
the vessel to the synovium or capsule of axillary region, 
which is thought to be the result of synovial and/or capsular 
inflammation. Our PET/CT study supports previous results 
suggesting the pathologic sites of FS; however, increased 
uptake on both RI and AR was not observed in all patients. 
In fact, only 11 patients (31%) showed increased uptake 
at both the sites. This finding suggests that the pathologic 
process of RI and AR do not always occur simultaneously, 
although this study is a cross-sectional observation. The 
involvement of RI and AR can be simultaneous or sequen-
tial or separate. Mean SUVmax values of AR and RI were 
significantly higher than those of AJC. No patients had a 
greater SUVmax in AJC than AR or RI. It is unclear why 
the SUVmax of AJC was lower than AR or RI. AJC may be 
a secondary pathologic site following inflammation in RI 
or AR. Although the differences in SUVmax of PJC were 
statistically significant between the affected and unaffected 
shoulders, it may be the result of spreading inflammation 
since the mean SUVmax of PJC at the affected shoulder 
was low and the differences between shoulders were mini-
mal. Further research is necessary to clarify synovial geo-
graphic differences of the molecular basis in the pathogen-
esis of FS.
Codman [20] described restricted external rotation 
movement as one of the features of FS. Clinical investiga-
tions confirmed that the contracture of the coracohumeral 
ligament restricted external rotation movement which is 
characteristic pathology in FS [21, 22]. Therefore, release 
of the coracohumeral ligament and thickening capsular 
release are believed to be the gold standard in the treatment 
of refractory FS. However, there has been a controversy 
regarding the extent of capsular release. Some authors 
suggest that the extent of inferior glenohumeral ligament 
release should be minimized to prevent damage to the axil-
lary nerve [23, 24], but others reported that global or addi-
tive posterior capsular release enhanced ROMs [25, 26]. 
In the present study, our results suggest that extensive cap-
sular release including posterior capsule is not necessary, 
but inferior and posterior portions of inferior glenohumeral 
ligament should be included. Also, individualized capsu-
lar release may affect postoperative outcomes. We expect 
that in patients with an RI dominant type, inferior capsular 
release will not improve ROM compared to RI and anterior 
capsular release. In patients with AR or both RI and AR 
dominant type, the results of anterior and inferior capsular 
release may be better than anterior capsular release only.
In general, the clinical diagnosis of FS is based on phy-
sicians’ physical examination, history taking and negative 
plain image. There have been clinical efforts to define if 
consistent patterns or absolute extent of ROM limitation 
could differentiate FS from other conditions with painful 
stiffness. The capsular pattern proposed by Cyriax suggests 
that the external rotation is most limited followed by abduc-
tion and then internal rotation [13]. However, following 
kinematic studies did not support Cyriax’s proposed con-
sistent glenohumeral capsular pattern [14, 15]. Rundquist 
et al. [14] demonstrated that with the arm abducted, internal 
Table 4  Correlation between clinical scores and regional metabolic 
parameters
VAS pain score ASES score SSV
RI—SUVmax r 0.00 −0.09 0.00
p value 0.995 0.597 0.995
AJC—SUVmax r −0.05 −0.09 −0.23
p value 0.764 0.597 0.186
AR—SUVmax r 0.04 −0.16 −0.05
p value 0.817 0.401 0.792
PJC—SUVmax r 0.12 −0.15 −0.10
p value 0.493 0.701 0.556
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rotation was the most limited motion in most patients. The 
present study suggested that inconsistent patterns of ROM 
limitation in FS might be related to different areas of cap-
sular inflammation and subsequent fibrosis. Several reports 
explained the relative contributions of specific portions of 
the capsule in limiting rotation in cadavers [27, 28]. For 
example, the whole inferior glenohumeral ligament resists 
internal rotation from 70° to 90° abduction and the superior 
glenohumeral ligament resists external rotation at 0° abduc-
tion [27, 28]. However, our results in patients with FS were 
somewhat different from previous studies using cadavers. 
The SUVmax of AR was related to abduction and forward 
flexion and not external rotation, while the SUVmax of RI 
was related to external rotation and internal rotation. Con-
sidering difference between ours and cadaveric studies, we 
have three possibilities to consider. First, the restriction of 
shoulder motion in patients with FS may be affected by 
factors other than capsular components. Pain during move-
ment in specific directions may cause restriction in these 
directions, similar to the cadaveric studies. Second, PET/
CT does not reflect the fibrotic contraction of joint capsule, 
but rather indirectly shows inflammation of the joint cap-
sule or synovium. Increased uptake in a specific area may 
not guarantee to develop fibrosis. Third, RI including cora-
cohumeral ligament and superior glenohumeral ligament 
can resist internal rotation as well as external rotation and 
AR including inferior glenohumeral ligament may also 
limit forward flexion and abduction movement. We believe 
that these findings will help determine the most effective 
site of corticosteroid injection for the treatment of FS. 
Additional research is needed to evaluate the effect of cor-
ticosteroid injection sites according to uptake patterns or 
patterns of ROM limitation. Another finding of the present 
study is that metabolic parameters did not correlate with 
clinical scores including VAS pain score, ASES score, and 
SSV. Although SUVmax values measured at the four ROIs 
correlated with ROMs, they did not affect subjective pain 
and functional scale of the patients.
There are several limitations in this study. First, the sam-
ple size was too small to definitively classify patterns of 
18F-FDG uptake in FS. Second, this study was conducted 
as a cross-sectional observational study. Our results do not 
guarantee that we fully understand the entire pathologic 
process in patients with FS because we did not evaluate 
enrolled patients longitudinally. Finally, our most weak 
point is the problem of radiation hazard. To minimize expo-
sure of radiation, we did our best to take regional images 
and use low doses of 18F-FDG thus ensuring that radiation 
exposure was negligible. Nevertheless, our study has some 
strong points. We applied strict inclusion criteria to exclude 
secondary FS. Systemic metabolic diseases related to FS 
were also excluded. Patient characteristics were homoge-
neous in that most patients were stage II according to the 
Hannafin and Chiaia criteria and the duration of symptoms 
was relatively short. We think that our results may repre-
sent PET/CT features of the freezing phase in FS. To the 
best of our knowledge, our study is the first to quantita-
tively evaluate PET/CT in idiopathic FS excluding systemic 
diseases and to analyze the correlation between ROM limi-
tation and images.
In conclusion, our study demonstrates that anteroinferior 
capsular portion, including RI and AR is the main patho-
logic site of idiopathic FS and reveals significant correla-
tion between ROM and metabolic parameters on 18F-FDG 
PET/CT. These results imply that AR and RI lesions are 
related to elevational limitations and rotational limitations, 
respectively. These findings may help guide the best strat-
egy for treatment including the most appropriate sites of 
corticosteroid injection and the extent of capsular release 
during arthroscopic surgery.
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